Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 21908585)

Published in Circ Heart Fail on September 09, 2011

Authors

Corline Brouwers1, Johan Denollet, Nicolaas de Jonge, Kadir Caliskan, Jennifer Kealy, Susanne S Pedersen

Author Affiliations

1: Department of Medical Psychology and Neuropsychology, CoRPS, Tilburg University, Tilburg, The Netherlands.

Articles by these authors

Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol (2003) 3.67

Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol (2010) 3.23

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol (2010) 2.50

Disease-specific health status as a predictor of mortality in patients with heart failure: a systematic literature review and meta-analysis of prospective cohort studies. Eur J Heart Fail (2014) 2.13

Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Int J Cardiol (2012) 2.04

Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm (2012) 1.91

Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm (2010) 1.85

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res (2009) 1.83

Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation (2008) 1.78

Type D personality, cardiac events, and impaired quality of life: a review. Eur J Cardiovasc Prev Rehabil (2003) 1.75

Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J (2007) 1.72

B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem (2004) 1.70

The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer (2011) 1.69

Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail (2012) 1.64

Adverse reactions after the use of sulphur hexafluoride (SonoVue) echo contrast agent. J Cardiovasc Med (Hagerstown) (2009) 1.56

Non-compaction cardiomyopathy is associated with mitral annulus enlargement and functional impairment: a real-time three-dimensional echocardiographic study. J Heart Valve Dis (2008) 1.56

Paradoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction. Am J Cardiol (2006) 1.55

The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation (2006) 1.53

Response to cardiac resynchronization therapy: is it time to expand the criteria? Pacing Clin Electrophysiol (2009) 1.52

Type D personality and health status in cardiovascular disease populations: a meta-analysis of prospective studies. Eur J Prev Cardiol (2011) 1.49

Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research. Pacing Clin Electrophysiol (2010) 1.49

Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox. Int J Cardiol (2012) 1.48

Proteomic profiling of the human failing heart after left ventricular assist device support. J Heart Lung Transplant (2011) 1.47

Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS One (2013) 1.47

The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes (2009) 1.44

Reduced regional systolic function is not confined to the noncompacted segments in noncompaction cardiomyopathy. Int J Cardiol (2008) 1.42

Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med (2010) 1.42

The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet (2010) 1.41

Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace (2012) 1.41

End stage of arrhythmogenic cardiomyopathy with severe involvement of the interventricular septum. Heart Rhythm (2012) 1.40

Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology. Eur J Heart Fail (2013) 1.39

Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation. Transplantation (2013) 1.39

Attitudes towards implantable cardioverter-defibrillator therapy: a national survey in Danish health-care professionals. Europace (2010) 1.39

A successful 4S heart transplantation. Can J Cardiol (2011) 1.39

Beta-blockers and depression in elderly hypertension patients in primary care. Fam Med (2014) 1.38

Validity of the Type D personality construct in Danish post-MI patients and healthy controls. J Psychosom Res (2004) 1.32

Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med (2005) 1.32

Usefulness of type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol (2006) 1.28

Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J (2005) 1.27

Negative affectivity and social inhibition in cardiovascular disease: evaluating type-D personality and its assessment using item response theory. J Psychosom Res (2007) 1.26

Validating the Type D personality construct in Chinese patients with coronary heart disease. J Psychosom Res (2010) 1.23

Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J (2008) 1.20

Failure to consult for symptoms of heart failure in patients with a type-D personality. Heart (2007) 1.17

Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiatry (2009) 1.15

Analysis of aortic valve commissural fusion after support with continuous-flow left ventricular assist device. Interact Cardiovasc Thorac Surg (2013) 1.15

Heterogeneous Connexin43 distribution in heart failure is associated with dispersed conduction and enhanced susceptibility to ventricular arrhythmias. Eur J Heart Fail (2010) 1.15

The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil (2005) 1.14

Psychological predictors of prognosis in chronic heart failure. J Card Fail (2008) 1.13

Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J (2008) 1.12

Predictive value of social inhibition and negative affectivity for cardiovascular events and mortality in patients with coronary artery disease: the type D personality construct. Psychosom Med (2013) 1.11

Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study. Stroke (2002) 1.11

Reorganized PKA-AKAP associations in the failing human heart. J Mol Cell Cardiol (2011) 1.10

E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trial. Psychosom Med (2014) 1.10

Increased anxiety and depression in Danish cardiac patients with a type D personality: cross-validation of the Type D Scale (DS14). Int J Behav Med (2009) 1.10

Assessment of the type D personality construct in the Korean population: a validation study of the Korean DS14. J Korean Med Sci (2010) 1.09

Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure. J Clin Psychiatry (2009) 1.08

Type D personality and cardiac mortality in patients with chronic heart failure. Int J Cardiol (2009) 1.07

Type-D personality is a stable taxonomy in post-MI patients over an 18-month period. J Psychosom Res (2007) 1.07

Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. Health Qual Life Outcomes (2010) 1.07

Inadequate consultation behavior modulates the relationship between type D personality and impaired health status in chronic heart failure. Int J Cardiol (2009) 1.06

Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation (2007) 1.06

Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms. J Pers Assess (2007) 1.06

Minimally invasive, off-pump explant of a continuous-flow left ventricular assist device. J Heart Lung Transplant (2010) 1.04

Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res (2007) 1.02

Somatic depression predicts mortality in chronic heart failure: can this be explained by covarying symptoms of fatigue? Psychosom Med (2012) 1.01

Poor health-related quality of life is a predictor of early, but not late, cardiac events after percutaneous coronary intervention. Psychosomatics (2007) 1.00

Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol (2005) 1.00

Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. Am Heart J (2010) 1.00

Noncardiac chest pain in the emergency department: the role of cardiac history, anxiety or depression and Type D personality. Eur J Cardiovasc Prev Rehabil (2007) 0.99

Left ventricular solid body rotation in non-compaction cardiomyopathy: a potential new objective and quantitative functional diagnostic criterion? Eur J Heart Fail (2008) 0.98

Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J Affect Disord (2011) 0.98

Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient. JIMD Rep (2011) 0.98

Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med (2009) 0.97

Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant (2006) 0.97

Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. Eur J Cardiovasc Prev Rehabil (2007) 0.97

Positive affect dimensions and their association with inflammatory biomarkers in patients with chronic heart failure. Biol Psychol (2012) 0.97

Type D personality is associated with increased metabolic syndrome prevalence and an unhealthy lifestyle in a cross-sectional Dutch community sample. BMC Public Health (2010) 0.96

Dose-dependent benefit of nitroglycerin on microcirculation of patients with severe heart failure. Intensive Care Med (2009) 0.96

Preliminary evidence for the cross-cultural utility of the type D personality construct in the Ukraine. Int J Behav Med (2009) 0.96

Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant (2006) 0.96

The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure. Basic Res Cardiol (2009) 0.96

Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol (2009) 0.95

Löffler endocarditis: a rare cause of acute cardiac failure. J Cardiothorac Surg (2012) 0.95

Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol (2008) 0.95

Dimensionality of the hospital anxiety and depression scale (HADS) in cardiac patients: comparison of Mokken scale analysis and factor analysis. Assessment (2010) 0.95

Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Disord (2006) 0.95

Validity of the hospital anxiety and depression scale for use with patients with noncardiac chest pain. Psychosomatics (2003) 0.95

Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol (2006) 0.95

Poor perceived social support in implantable cardioverter defibrillator (ICD) patients and their partners: cross-validation of the multidimensional scale of perceived social support. Psychosomatics (2009) 0.95

Tele-guidance of chronic heart failure patients enhances knowledge about the disease. A multi-centre, randomised controlled study. Eur J Heart Fail (2008) 0.94